SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001213900-24-028040
Filing Date
2024-03-29
Accepted
2024-03-29 17:00:56
Documents
4
Effectiveness Date
2024-03-29

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea0202044-s8_actiniumpharma.htm S-8 34998
2 OPINION OF HAYNES AND BOONE, LLP ea020204401ex5-1_actinium.htm EX-5.1 8963
3 CONSENT OF MARCUM LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ea020204401ex23-1_actinium.htm EX-23.1 2472
4 FILING FEE TABLE ea020204401ex-fee_actinium.htm EX-FILING FEES 11803
  Complete submission text file 0001213900-24-028040.txt   59368
Mailing Address 100 PARK AVE., 23RD FLOOR NEW YORK NY 10017
Business Address 100 PARK AVE., 23RD FLOOR NEW YORK NY 10017 (646) 677-3870
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

IRS No.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-278395 | Film No.: 24804675
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)